Clinical Trial Update: CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes in Non-diabetic ACS Patients Without HF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating SGLT2 inhibitor–related changes in pericoronary fat using coronary CT angiography in non-diabetic acute coronary syndrome pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: ACS (Acute Coronary Syndrome), SGLT2 Inhibitors | Phase 4 | Status: NOT_YET_RECRUITING